跳至主要内容
临床试验/ChiCTR2100042595
ChiCTR2100042595已完成Unknown

Short Term and Sustained EyePressure Changes after Intraocular injection of Bevacizumab in Diabetic Retinopathy Patients

未提供1 个研究点 分布在 1 个国家开始时间: 2020年1月15日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
试验地点
1
主要终点
IOP

研究概览

简要总结

To determine the short term and sustained intra-ocular pressure (IOP) changes after intravitreal injection of bevacizumab in patients with diabetic retinopathy (DR).

研究设计

研究类型
Interventional
主要目的
单臂
盲法
N/a

入排标准

年龄范围
40 至 60(—)
性别
All

入选标准

  • Patients giving consent;
  • Patients of both gender aged between 18-60 years;
  • Diabetic patients with indication for intravitreal anti-VEGF treatment, including CSME (as per operational definition) and PDR without any traction on retina.

排除标准

  • Patients who had intravitreal injections of triamcinolone acetonide any time up until 6 months prior to the study.
  • Patients with active uveitis or ocular ischemic syndrome.
  • Diagnosed with any type of glaucoma or pre injection ocular hypertension.
  • History of any intraocular surgery.
  • History of use systemic steroids or beta- blockers.

研究组 & 干预措施

case series

结局指标

主要结局

IOP

次要结局

未报告次要终点

研究者

发起方
未提供

研究点 (1)

Loading locations...

相似试验